BHB and Ketone Supplements: What the Evidence Shows

Evidence Review

Anti-inflammatory Signaling Discovery (Youm et al., 2015)

The landmark paper establishing BHB's role as a signaling metabolite, published in Nature Medicine, found that BHB — but not acetoacetate or structurally similar fatty acids like butyrate — directly inhibits the NLRP3 inflammasome. The mechanism involves prevention of potassium efflux and suppression of ASC oligomerization (the scaffolding step that activates caspase-1 to generate IL-1β). In vivo, BHB attenuated caspase-1 activation and IL-1β secretion in mouse models of Muckle-Wells Syndrome, familial cold autoinflammatory syndrome, and urate crystal-induced inflammation. This paper, co-authored by 17 researchers across Yale, Vanderbilt, and other institutions, established that ketosis is not merely an energy state but an active anti-inflammatory condition mediated by BHB at the molecular level [1].

Comprehensive Signaling Review (Newman & Verdin, 2017)

This Annual Review of Nutrition article by researchers at UC San Francisco and the Buck Institute synthesized the known signaling functions of BHB beyond its role as fuel: HDAC inhibition that upregulates FOXO3a and metallothionein genes (involved in stress resistance); GPR109a activation modulating adipocyte and immune cell function; and lysine-beta-hydroxybutyrylation — a post-translational histone modification distinct from acetylation, newly identified at the time. The review noted that blood BHB levels of 0.5–2.0 mM — achievable through intermittent fasting, ketogenic diet, or exogenous supplementation — appear sufficient to engage most of these signaling pathways [2].

Cerebral Blood Flow and Cognition RCT (Walsh et al., 2021)

This placebo-controlled, double-blind, 14-day cross-over trial recruited 14 adults with obesity consuming 12g BHB three times daily. Cerebral blood flow was measured by duplex ultrasound in four vessels; cognition by DSST, Stroop, and trail-making. Results: carotid artery flow +12%, vertebral artery +11%, and DSST performance +2.7 correct responses (Cohen's d = 0.56, statistically significant). The authors concluded that ketone supplementation may improve brain energy supply through enhanced perfusion, particularly in individuals with reduced cerebral insulin sensitivity. Limitations: small sample (n=14), obesity-specific population, 14-day duration — replication in larger and more diverse samples is needed [3].

Dopamine Maintenance in Ultra-Endurance (Poffé et al., 2023)

Eighteen recreational runners were randomized to ketone ester (approximately 25g, R-3-hydroxybutyl R-3-hydroxybutyrate) or noncaloric placebo during a 100km trail run. Blood samples at regular intervals showed plasma dopamine doubling from baseline in the ketone group during the run while remaining flat in the placebo group (post-run: 4.1 ± 1.7 nM vs. 2.4 ± 0.8 nM, p = 0.048). Cognitive testing showed placebo runners' visual reaction times deteriorated 19% and movement execution times 41% across the race; both changes were fully absent in the ketone ester group (p < 0.05). These results suggest exogenous ketones support catecholamine synthesis during extreme endurance stress, a novel mechanism distinct from purely energetic effects [4].

Athletic Performance Systematic Review (Evans et al., 2022)

This comprehensive 43-page review in Sports Medicine synthesized the growing ketone and exercise literature. Key conclusions: (1) Ketone esters suppress glycolysis and lactate production acutely — this does not benefit power output in short-duration efforts but may be metabolically advantageous in prolonged events. (2) Co-ingestion with carbohydrates is better tolerated than ketones alone. (3) The most consistently documented sports benefit is psychocognitive — preserved attention, mental alertness, and decision-making during prolonged fatigue — rather than physical power or speed. The review identified significant heterogeneity across studies in dose, formulation, exercise modality, and population, making meta-analytic conclusions difficult [5].

28-Day Safety Study (Soto-Mota et al., 2019)

Twenty-four healthy adults (aged 18–70) consumed 26.8g of ketone monoester three times daily for 28 consecutive days — achieving blood BHB of approximately 4.1 mM three times per day. Standard metabolic panel, lipid profile, kidney function, body composition, and blood gases were unchanged from baseline at 28 days. Mild nausea was reported following 6 of 2,016 individual drinks administered (0.3% incident rate). This study provides the most robust available safety data for sustained ketone supplementation at doses used in research [6].

Confidence and Limitations

The anti-inflammatory mechanisms are well-characterized at the molecular level in rodent models. Human evidence for cognitive and cerebrovascular benefit is promising but limited to small trials in specific populations. Athletic performance evidence is mixed — mental and psychocognitive benefits are more consistent than physical performance benefits. The gap between mechanistic data and human outcome data remains substantial. Commercially available ketone salts are typically less potent than the ketone esters used in research. The field is evolving rapidly, and forthcoming larger RCTs — several currently registered — should clarify the dose-response and population-specificity of these effects.